<p>Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD.  Related Content:</p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.6025?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US</a></li> </ul>

Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

<p>Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD.  Related Content:</p> <ul> <li><a href="https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.6025?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" rel="noopener noreferrer">Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US</a></li> </ul>

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Share Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Sign up to save your podcasts

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

More shows like JAMA Oncology Author Interviews

JAMA Editors' Summary

EMCrit FOAM Feed

NEJM This Week

Journal of Clinical Oncology (JCO) Podcast

This Week in Cardiology

JAMA Clinical Reviews

JAMA Pediatrics Editors' Summary

ASCO Daily News

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

JAMA Cardiology Author Interviews

JAMA Dermatology Author Interviews

JAMA Internal Medicine Author Interviews

JAMA Neurology Author Interviews

JAMA Ophthalmology Author Interviews

JAMA Otolaryngology–Head & Neck Surgery Author Interviews

JAMA Pediatrics Author Interviews

JAMA Psychiatry Author Interviews

JAMA Medical News

ASCO Guidelines

JAMAevidence Care at the Close of Life

JAMAevidence The Rational Clinical Examination

JAMAevidence Users' Guides to the Medical Literature

Annals On Call Podcast

Plenary Session

JAMA Network Open Conversations

Coronavirus (COVID-19) Q&A

JAMAevidence JAMA Guide to Statistics and Methods

The Curious Clinicians

JAMA Health Forum Conversations

JAMA Author Interviews

Two Onc Docs